UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Investing in your 20s can set the foundation for a secure retirement. Discover the best options to maximize your growth.
17,677 articlesAs UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
In February, Occidental Petroleum’s stock surged nearly 17%, powered by higher oil prices and strong earnings signals...
What to expect from Kodiak’s 2025 earnings? This guide breaks down revenue drivers, margins, and realistic scenarios ...
SNDL investors are keenly watching Q4 2025 earnings for a read on revenue mix, cost discipline, and debt strategy. Th...
Geopolitical tensions are sparking volatility in the helium market. This report explains how a disruption in helium s...
When leadership shifts at Berkshire Hathaway, the market takes notice. This piece explains how greg abel just took cu...
Nokia climbs on 5G demand and North American telecom spend, while broader markets drift. A practical look at what thi...
Unpack GEO Group's Q1 2026 earnings through the transcript lens. Learn what drove revenue, how margins held up, and w...
Sunrun’s Thursday rally followed a robust first-quarter report, highlighting strong revenue growth and a surge in ene...
The next Fed chair choice could redefine the market landscape. This article breaks down what president donald trump's...
After a steep slide, Novo Nordisk has shown fresh momentum. But can the rebound sustain, or is it just a temporary bo...
Ares Capital's dividend looks tempting to many income investors, but sustainability hinges on cash flow, loan quality...